Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 9,745Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Biophore India Pharmaceuticals Private Limited

02 1Pharmacia & Upjohn Company LLC

03 1Curia Spain S.A.U.

04 1Hetero Labs Limited

05 2Industriale Chimica s.r.l.

06 1MSN Life Sciences Private Limited

07 1Optimus Drugs Private Limited

08 1Teva Czech Industries s.r.o

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

OBETICHOLIC ACID

NDC Package Code : 73435-004

Start Marketing Date : 2019-12-09

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (10kg/10kg)

Marketing Category : BULK INGREDIENT

Biophore

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPfizer CentreOne is a global CDMO and a leading supplier of Specialty APIs.

OBETICHOLIC ACID

NDC Package Code : 0009-0098

Start Marketing Date : 2021-05-14

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Pfizer centreOne

03

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

OBETICHOLIC ACID

NDC Package Code : 65089-0055

Start Marketing Date : 2016-05-27

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

04

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

OBETICHOLIC ACID

NDC Package Code : 68554-0121

Start Marketing Date : 2016-05-27

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

OBETICHOLIC ACID

NDC Package Code : 63190-0840

Start Marketing Date : 2016-05-27

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

OBETICHOLIC ACID

NDC Package Code : 63190-0830

Start Marketing Date : 2016-05-27

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

IMCAS Asia
Not Confirmed
arrow

09

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

OBETICHOLIC ACID

NDC Package Code : 47848-056

Start Marketing Date : 2016-12-13

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (100kg/100kg)

Marketing Category : BULK INGREDIENT

blank

Looking for 459789-99-2 / Obeticholic Acid API manufacturers, exporters & distributors?

Obeticholic Acid manufacturers, exporters & distributors 1

49

PharmaCompass offers a list of Obeticholic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Obeticholic Acid manufacturer or Obeticholic Acid supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Obeticholic Acid manufacturer or Obeticholic Acid supplier.

PharmaCompass also assists you with knowing the Obeticholic Acid API Price utilized in the formulation of products. Obeticholic Acid API Price is not always fixed or binding as the Obeticholic Acid Price is obtained through a variety of data sources. The Obeticholic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Obeticholic Acid

Synonyms

459789-99-2, 6-ecdca, Int-747, 6-ethylchenodeoxycholic acid, Ocaliva, Obetichloic acid

Cas Number

459789-99-2

Unique Ingredient Identifier (UNII)

0462Z4S4OZ

About Obeticholic Acid

Obeticholic Acid is an orally bioavailable semi-synthetic bile acid derivative and an agonist of the nuclear bile acid receptor farnesoid X receptor (FXR) that may be used to lower hepatic exposure to bile acids. Upon oral administration, obeticholic acid targets and binds to FXR expressed in the liver and intestine, activating FXR-mediated bile acid, inflammatory, fibrotic, and metabolic pathways. This suppresses the production of bile acid in the hepatocytes and increases bile acid transport out of the hepatocytes, thereby reducing hepatic exposure to bile acids. FXR plays an important role in bile acid homeostasis and is involved in hepatic and intestinal inflammation and liver fibrosis.

IU6 Manufacturers

A IU6 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of IU6, including repackagers and relabelers. The FDA regulates IU6 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. IU6 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of IU6 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

IU6 Suppliers

A IU6 supplier is an individual or a company that provides IU6 active pharmaceutical ingredient (API) or IU6 finished formulations upon request. The IU6 suppliers may include IU6 API manufacturers, exporters, distributors and traders.

click here to find a list of IU6 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

IU6 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing IU6 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for IU6 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture IU6 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain IU6 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a IU6 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of IU6 suppliers with NDC on PharmaCompass.

IU6 Manufacturers | Traders | Suppliers

IU6 Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.